highlights the incredible work our portfolio companies are doing to improve the health of people & planet

lands $65M from investors including Microsoft & Google to expand clean energy marketplace services

raises $100M Series A to build laser-driven nuclear fusion prototype system

announces a milestone $100M+ partnership with Regeneron to develop in-vivo CRISPR-based gene editing therapies

interviewed our co-founder Paul Straub on how Recurrent is transforming the used EV market

announces oversubscribed financing, bringing total Series B round to US$119 Million

partners with Google to help all organizations accelerate their journey to 24/7 carbon-free energy

founder Christine Moseley in Newsweek feature on women entrepreneurs creating new businesses in record numbers

raises $17M oversubscribed seed round to develop small molecule drugs that hit un-druggable proteins